In 2014, a patient with a microdeletion restricted to the BCL11A gene was described with neurodevelopmental delay, severe speech disorder, and attention deficit, thereby delineating these traits for the first time specifically to BCL11A [49]. This evidence concerns the gene BCL11A and speech disorder.